Fulcrum Capital LLC Eli Lilly & CO Transaction History

Fulcrum Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$180.55 - $233.54 $554,469 - $717,201	-3,071 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$164.32 - $212.72 $77,230 - $99,978	-470 Reduced 13.27%	3,071 $574,000
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $94,713 - $125,329	726 Added 25.79%	3,541 $598,000
Q3 2020 Oct 21, 2020	BUY	$146.22 - $169.13 $411,609 - $476,100	2,815 New	2,815 $417,000

4,015

739M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $748B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Fulcrum Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Fulcrum Capital LLC with notifications on news.